Skip NavigationSkip to Content

E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways

  1. Author:
    Phillips, A. C.
    Ernst, M. K.
    Bates, S.
    Rice, N. R.
    Vousden, K. H.
  2. Author Address

    Vousden KH NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program W 7th St Frederick, MD 21702 USA NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program Frederick, MD 21702 USA SmithKline Beecham Pharmaceut Harlow CM19 5AD Essex England
    1. Year: 1999
  1. Journal: Molecular Cell
    1. 4
    2. 5
    3. Pages: 771-781
  2. Type of Article: Article
  1. Abstract:

    The E2F family of transcription factors plays an essential role in promoting cell cycle progression, and one member of the family, E2F-1, is also capable of inducing apoptosis. We show here that E2F-1 can induce apoptosis by a death receptor-dependent mechanism, by downregulating TRAF2 protein levels and inhibiting activation of antiapoptotic signals including NF-kappa B. In this way, E2F-1 expression can lead to the sensitization of cells to apoptosis by a number of agents independently of p53. Deregulation of E2F-1 activity occurs in the majority of human tumors, and the ability of E2F-1 to inhibit antiapoptotic signaling may contribute to the enhanced sensitivity of transformed cells to chemotherapeutic agents. [References: 59]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel